The life sciences sector is being reevaluated, with a focus on expanding beyond traditional laboratory settings. Various aspects of the industry are being reexamined, including location strategies, patient care models, product development, and research approaches. The scope of this reevaluation appears to be broad, encompassing topics such as biotech innovation, lipid biology, and procurement practices.